Additional file 4: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Additional file 1: of Association of plasma soluble CD14 level with asthma severity in adults: a case control study in China

Ting Zhou (38572)
Xiji Huang (446775)
Jixuan Ma (4526053)
Yun Zhou (308977)
Yuewei Liu (170474)
Lili Xiao (3182601)
Jing Yuan (217967)
Jungang Xie (128006)
Weihong Chen (170472)

January 2019

Table S1. The Severity Scale of asthma patients in the Guidelines for Prevention and Treatment of Br...

Additional file 2: of Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis

Marlene Bloechliger (5148365)
Daphne Reinau (5148371)
Julia Spoendlin (806756)
Shih-Chen Chang (494894)
Klaus Kuhlbusch (5148368)
Liam Heaney (397968)
Susan Jick (5120306)
Christoph Meier (1293756)

April 2018

Flowchart of the study population. Detailed information on characteristics and co-medication of case...

Additional file 3: Figure S2. of Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma

Paul OâByrne (3526901)
Loretta Jacques (810725)
Caroline Goldfrad (56320)
Namhee Kwon (3526892)
Michael Perrio (3526895)
Louisa Yates (3526898)
William Busse (3466799)

November 2016

Plot of serious pneumonia incidence per 1000 patient-years and 95% CI by treatment group (integrated...

Additional file 1: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

Profile of the three Phase III studies included in both the efficacy and safety analyses. (DOCX 47.4...

Additional file 8: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

AEs reported by âĽ3 patients in the Japan+Korea cohort of any relevant treatment arm and the corres...

Additional file 2: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

Profile of the two additional Phase IIb studies included in only the safety analyses. (DOCX 25.6 KB

Additional file 9: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

Region ratios of ‘treatment effect’ in Japan+Korea and Not-Japan+Korea patients, where ‘treatment ef...

Additional file 3: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

List of Institutions and Independent Ethics Committees/Institutional Review Boards for Studies HZA10...

Additional file 5: Figure S2. of Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study

Jean Bousquet (20909)
Neil Barnes (3604997)
Michael Gibbs (3988391)
Nadeem Gul (3988394)
Susan Tomkins (3988397)
Xin Zhou (54275)
Young-Joo Cho (504038)
Hae-Sim Park (678741)
William Busse (3466799)
Nanshan Zhong (46591)

April 2017

Asthma quality of life questionnaire score (pooled data) in Asian and non-Asian patients, at baselin...

Additional file 6: Table S3. of Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study

Jean Bousquet (20909)
Neil Barnes (3604997)
Michael Gibbs (3988391)
Nadeem Gul (3988394)
Susan Tomkins (3988397)
Xin Zhou (54275)
Young-Joo Cho (504038)
Hae-Sim Park (678741)
William Busse (3466799)
Nanshan Zhong (46591)

April 2017

Summary of the most common adverse events (âĽ5%) in the Asian and non-Asian populations. (DOCX 24 k...

Additional file 1: of Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthmaâmixed treatment comparisons of clinical efficacy

Henrik Svedsater (3469295)
Gillian Stynes (3469289)
Jaro Wex (3469301)
Lucy Frith (3469304)
David Leather (3469286)
Emanuela Castelnuovo (3469298)
Michelle Detry (3469292)
Scott Berry (32788)

February 2016

e-table 1: Characteristics of the studies and treatment arms included in the MTC. e-table 2: Results...

Additional file 1: of Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial

George Bardsley (5511125)
Peter Daley-Yates (4332277)
Amanda Baines (5511122)
Rodger Kempsford (5511116)
Mathew Williams (460953)
Tony Mallon (5511131)
Irene Braithwaite (463107)
Kylie Riddell (5511128)
Shashidhar Joshi (5511113)
Philippe Bareille (5511119)
Richard Beasley (239695)
James Fingleton (3728818)

July 2018

Supplementary appendix: The anti-inflammatory duration of action of fluticasone furoate/vilanterol t...

Additional file 4: Table S1. of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

Proportion of patients achieving an increase FEV1 ≥ 0.100 L above baseline at various times post-dos...

Additional file 5: Table S2. of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

Results from the analyses reporting proportions of patients achieving lung function improvements for...

Additional file 6: Table S3. of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

Results from the analyses of FVC other endpoints (selected) (ITT population). (DOC 43Â kb

Additional file 1: of Association of plasma soluble CD14 level with asthma severity in adults: a case control study in China

Ting Zhou (38572)
Xiji Huang (446775)
Jixuan Ma (4526053)
Yun Zhou (308977)
Yuewei Liu (170474)
Lili Xiao (3182601)
Jing Yuan (217967)
Jungang Xie (128006)
Weihong Chen (170472)

January 2019

Table S1. The Severity Scale of asthma patients in the Guidelines for Prevention and Treatment of Br...

Additional file 2: of Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis

Marlene Bloechliger (5148365)
Daphne Reinau (5148371)
Julia Spoendlin (806756)
Shih-Chen Chang (494894)
Klaus Kuhlbusch (5148368)
Liam Heaney (397968)
Susan Jick (5120306)
Christoph Meier (1293756)

April 2018

Flowchart of the study population. Detailed information on characteristics and co-medication of case...

Additional file 3: Figure S2. of Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma

Paul OâByrne (3526901)
Loretta Jacques (810725)
Caroline Goldfrad (56320)
Namhee Kwon (3526892)
Michael Perrio (3526895)
Louisa Yates (3526898)
William Busse (3466799)

November 2016

Plot of serious pneumonia incidence per 1000 patient-years and 95% CI by treatment group (integrated...

Additional file 1: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

Profile of the three Phase III studies included in both the efficacy and safety analyses. (DOCX 47.4...

Additional file 8: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

AEs reported by âĽ3 patients in the Japan+Korea cohort of any relevant treatment arm and the corres...

Additional file 2: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

Profile of the two additional Phase IIb studies included in only the safety analyses. (DOCX 25.6 KB

Additional file 9: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

Region ratios of ‘treatment effect’ in Japan+Korea and Not-Japan+Korea patients, where ‘treatment ef...

Additional file 3: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

List of Institutions and Independent Ethics Committees/Institutional Review Boards for Studies HZA10...

Additional file 5: Figure S2. of Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study

Jean Bousquet (20909)
Neil Barnes (3604997)
Michael Gibbs (3988391)
Nadeem Gul (3988394)
Susan Tomkins (3988397)
Xin Zhou (54275)
Young-Joo Cho (504038)
Hae-Sim Park (678741)
William Busse (3466799)
Nanshan Zhong (46591)

April 2017

Asthma quality of life questionnaire score (pooled data) in Asian and non-Asian patients, at baselin...

Additional file 6: Table S3. of Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study

Jean Bousquet (20909)
Neil Barnes (3604997)
Michael Gibbs (3988391)
Nadeem Gul (3988394)
Susan Tomkins (3988397)
Xin Zhou (54275)
Young-Joo Cho (504038)
Hae-Sim Park (678741)
William Busse (3466799)
Nanshan Zhong (46591)

April 2017

Summary of the most common adverse events (âĽ5%) in the Asian and non-Asian populations. (DOCX 24 k...

Additional file 1: of Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthmaâmixed treatment comparisons of clinical efficacy

Henrik Svedsater (3469295)
Gillian Stynes (3469289)
Jaro Wex (3469301)
Lucy Frith (3469304)
David Leather (3469286)
Emanuela Castelnuovo (3469298)
Michelle Detry (3469292)
Scott Berry (32788)

February 2016

e-table 1: Characteristics of the studies and treatment arms included in the MTC. e-table 2: Results...

Additional file 1: of Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial

George Bardsley (5511125)
Peter Daley-Yates (4332277)
Amanda Baines (5511122)
Rodger Kempsford (5511116)
Mathew Williams (460953)
Tony Mallon (5511131)
Irene Braithwaite (463107)
Kylie Riddell (5511128)
Shashidhar Joshi (5511113)
Philippe Bareille (5511119)
Richard Beasley (239695)
James Fingleton (3728818)

July 2018

Supplementary appendix: The anti-inflammatory duration of action of fluticasone furoate/vilanterol t...

Additional file 4: Table S1. of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

Proportion of patients achieving an increase FEV1 ≥ 0.100 L above baseline at various times post-dos...

Additional file 5: Table S2. of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

Results from the analyses reporting proportions of patients achieving lung function improvements for...

Additional file 6: Table S3. of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

Results from the analyses of FVC other endpoints (selected) (ITT population). (DOC 43Â kb

Additional file 1: of Association of plasma soluble CD14 level with asthma severity in adults: a case control study in China

Ting Zhou (38572)
Xiji Huang (446775)
Jixuan Ma (4526053)
Yun Zhou (308977)
Yuewei Liu (170474)
Lili Xiao (3182601)
Jing Yuan (217967)
Jungang Xie (128006)
Weihong Chen (170472)

January 2019

Table S1. The Severity Scale of asthma patients in the Guidelines for Prevention and Treatment of Br...

Additional file 2: of Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis

Marlene Bloechliger (5148365)
Daphne Reinau (5148371)
Julia Spoendlin (806756)
Shih-Chen Chang (494894)
Klaus Kuhlbusch (5148368)
Liam Heaney (397968)
Susan Jick (5120306)
Christoph Meier (1293756)

April 2018

Flowchart of the study population. Detailed information on characteristics and co-medication of case...

Additional file 3: Figure S2. of Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma

Paul OâByrne (3526901)
Loretta Jacques (810725)
Caroline Goldfrad (56320)
Namhee Kwon (3526892)
Michael Perrio (3526895)
Louisa Yates (3526898)
William Busse (3466799)

November 2016

Plot of serious pneumonia incidence per 1000 patient-years and 95% CI by treatment group (integrated...

Additional file 4: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Abstract

Extracted data

Additional file 4: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Abstract

Extracted data

Related items

Related items